Joshua Fitch, Senior Editor

Take a quick look at our top 10 headlines from the first quarter of 2026.

Take a look back at some of the top FDA-related news items—from de Novo clearances to advancing trials—that Contemporary OB/GYN covered in the first quarter of 2026.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

From FDA regulatory updates for products related to women's health, to a preview of upcoming annual meetings and conferences, we keep you updated on what's to come in Q2 of 2026.

The FDA informed manufacturers of its intent to issue draft guidance by August 2026 to regulate unapproved animal-derived thyroid medications used by 1.5 million Americans.

Researchers reported in JAMA Health Forum that while expanded prenatal syphilis mandates improve near-term detection, they require additional public health support to maintain long-term efficacy.

Willow Innovations launched 7 new breastfeeding and maternal care accessories to support postpartum care from feeding to storage of breast milk.

Livi is a single-use, soft polyurethane foam device cleared by the FDA to absorb semen and vaginal discharge within approximately 60 seconds.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

ENDO-205 is EndoCyclic Therapeutics' lead program and consists of a first-in-class, non-hormonal targeted epeptide therapeutic for endometriosis, according to the company.

Flo Health chief medical officer Anna Klepchukova and study investigator Erica Stockwell highlight the benefits of digital symptom checkers for endometriosis.

Among a survey of over 800 providers, menopause care was the top area for expected greatest improvement over the next 5 years.

Among 2029 women in Scandinavian countries who were followed up for 14 years, vaccine effectiveness was 100%.

A randomized clinical trial found that weekly extended-release buprenorphine achieved significantly higher illicit opioid abstinence during pregnancy compared to daily sublingual doses.

Data suggest that thermal biomodulation via radiofrequency improves vaginal lubrication and reduces pain during intercourse for postmenopausal women.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A longitudinal study found that third-trimester levels of sFlt-1 and hs-cTnI were an independently associated with higher long-term CVD risk.

Clinicians are advised to discuss reproductive risks and fertility preservation options with all cancer patients prior to initiating therapy to maximize future reproductive potential.

According to FLO Living, the Cycle Syncing Method resulted in 92% of participants reporting meaningful reductions in the number and intensity of PMS symptoms after 60 days.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

An expert infectious disease panel discusses how recent federal vaccine schedule changes can impact maternal immunizations and potential repercussions.

Research indicates that LMWH prophylaxis effectively mitigates the high risk of pregnancy loss and reduced natural fecundity associated with protein S deficiency.

The Menopause Society reported new data from 68 health organizations that showed vaginal estrogen therapy does not elevate recurrence risk in survivors aged 18 to 51.

Results from the TITAN 2 study presented at SUFU 2026 demonstrate that the Altaviva ITNM system provides sustained reduction in UUI episodes and improved quality of life through 24 months.

Data published in npj Digital Medicine indicates that digital symptom checkers for endometriosis can reduce diagnostic delay by over 4 years and save more than $5,000 per patient.

The FDA has cleared a cloud-based AI tool that predicts delivery dates solely from ultrasound images.

Research published in The BMJ indicates that individuals vaccinated against HPV before age 17 experience a 79% reduction in invasive cervical cancer risk compared to unvaccinated peers.

Researchers reported that lidocaine did not affect POUR rates but enhanced early recovery metrics after SUI surgery.

A global analysis found significant disparities in magnesium sulfate use for preterm birth, particularly between higher- and middle-income countries.